Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhengzhou Gata Biotechnology is a specialized biotechnology company headquartered in Zhengzhou, China, dedicated to the development and manufacture of high-quality biological reagents. The company's core expertise lies in the production of recombinant proteins, including cytokines, growth factors, and viral antigens, which serve as critical raw materials for the diagnostic and pharmaceutical industries. Gata Biotechnology also provides comprehensive CRO services, offering tailored solutions for protein expression, antibody development, and purification across multiple expression systems. By leveraging its advanced technology platforms, the company supports global research efforts in oncology, immunology, and infectious diseases. Their commitment to quality and cost-efficiency has established them as a reliable partner for both academic institutions and commercial biotech firms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhengzhou Gata Biotechnology.